Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H PORTER

Showing results (661-670 of 676) with videos related to

Pageof 68
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 12, 2019
The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP groupMirko Koziolek, Stefano Alcaro, Patrick Augustijns, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2015
Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depressionLothar Lindemann, Richard H Porter, Sebastian H Scharf, et al.
Nature Metabolism|September 21, 2021
Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesityEnyuan Cao, Matthew J Watt, Cameron J Nowell, et al.
Nature Cancer|October 31, 2023
Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemiaClaudia Bruedigam, Amy H Porter, Axia Song, et al.
Science Translational Medicine|February 8, 2019
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancerMatthew J Watt, Ashlee K Clark, Luke A Selth, et al.
Science Translational Medicine|June 2, 2017
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain reliefDane D Jensen, TinaMarie Lieu, Michelle L Halls, et al.
Plos One|March 11, 2016
In Vitro and In Vivo Characterization of the Alkaloid NuciferineMartilias S Farrell, John D McCorvy, Xi-Ping Huang, et al.
The Prostate|March 7, 2024
Defining the challenges and opportunities for using patient-derived models in prostate cancer researchW Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, et al.
Biorxiv : the Preprint Server for Biology|July 12, 2026
Radioligand therapy in combination with CAR T cells overcomes the heterogeneous immunosuppressive prostate tumor microenvironmentJiangyue Liu, Iveta Fajnorova, Yuwei Ren, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2018
Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndromeNestor N Jimenez-Vargas, Luke A Pattison, Peishen Zhao, et al.
Pageof 68

Showing results (661-670 of 676) with videos related to

Sort By:
Pageof 68
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 12, 2019
The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP groupMirko Koziolek, Stefano Alcaro, Patrick Augustijns, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2015
Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depressionLothar Lindemann, Richard H Porter, Sebastian H Scharf, et al.
Nature Metabolism|September 21, 2021
Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesityEnyuan Cao, Matthew J Watt, Cameron J Nowell, et al.
Nature Cancer|October 31, 2023
Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemiaClaudia Bruedigam, Amy H Porter, Axia Song, et al.
Science Translational Medicine|February 8, 2019
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancerMatthew J Watt, Ashlee K Clark, Luke A Selth, et al.
Science Translational Medicine|June 2, 2017
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain reliefDane D Jensen, TinaMarie Lieu, Michelle L Halls, et al.
Plos One|March 11, 2016
In Vitro and In Vivo Characterization of the Alkaloid NuciferineMartilias S Farrell, John D McCorvy, Xi-Ping Huang, et al.
The Prostate|March 7, 2024
Defining the challenges and opportunities for using patient-derived models in prostate cancer researchW Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, et al.
Biorxiv : the Preprint Server for Biology|July 12, 2026
Radioligand therapy in combination with CAR T cells overcomes the heterogeneous immunosuppressive prostate tumor microenvironmentJiangyue Liu, Iveta Fajnorova, Yuwei Ren, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2018
Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndromeNestor N Jimenez-Vargas, Luke A Pattison, Peishen Zhao, et al.
Pageof 68